Sørensen et al. ([@B1]) report that in Norway, low concentration of 25-hydroxy-vitamin D \[25(OH)D\] in mothers during pregnancy was associated with an increased risk of type 1 diabetes in the offspring. We would like to point out that one putative confounding factor in their study might have been the intake of n-3 polyunsaturated fatty acids. Childhood n-3 fatty acid intake and status have been linked with the development of pretype 1 diabetes ([@B2]), while reasonably powered prospective studies of exposure during pregnancy are lacking. Of pregnant Norwegian women, 59% used cod liver or fish oil during pregnancy during the years 2002--2005 ([@B3]). In the study by Sørensen et al. ([@B1]), the samples were collected in 1992--1994. Cod liver oil contains both vitamin D and n-3 polyunsaturated fatty acids. Serum levels of 25(OH)D are likely to correlate with the intake of n-3 polyunsaturated fatty acids in a situation where the dietary sources of vitamin D and n-3 fatty acids are---to a large extent---the same.

A recently published Finnish study ([@B4]) with the similar nested case-control design did not find an association between maternal 25(OH)D concentration and the risk of type 1 diabetes in the offspring. In the study by Miettinen et al. ([@B4]), samples were collected in 1993--2000. Unlike in Norway, less than 2% of Finnish pregnant women consumed cod liver or fish oil supplements, whereas 30% of the women used other vitamin D containing supplements ([@B5]).

Another important difference is the much lower mean concentration of 25(OH)D during pregnancy in Finland than in Norway ([@B1],[@B4]). About 70% of the Finnish mothers had vitamin D insufficiency or deficiency \[25(OH)D \<50 nmol/L\], which may have lead to difficulties to discern any differences between the groups. Low serum levels of 25(OH)D in Finnish pregnant women reflect the low vitamin D intake. Mean maternal daily intake of vitamin D from diet was 5.1 μg and from supplements was 1.3 μg in Finland during the years 1997--2002 ([@B5]), whereas respective intakes were 3.5 μg and 10.1 μg in Norway ([@B3]). Possible other explanations for the different findings between the studies ([@B1],[@B4]) include the fact that the samples were collected mainly during the last trimester of pregnancy in Norway, and during the first trimester in Finland.
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